Facebook
X
LinkedIn
ForwardElucidating the When, Where, and Why of tau spread: Implications for diagnosis, prognosis, and novel treatment strategies - Elias Granadillo, MD
Series Overview
One hour didactic session where speakers deliver clinical, basic science and translational neurology and neuroscience related topics. Speakers include UW neurology department members, including neuropsychologists, researchers, clinical faculty, neurology residents. We also invite other UW clinicians and researchers or invited speakers from outside UW.
Intended Audience
MD/DO, RN, APRN, Physician Assistants, Psychologists, and Students.
Learning Objectives
As a result of participation in this educational activity, members of the healthcare team will:
- Describe our current understanding of the spatiotemporal spread of tau in Alzheimer’s Disease, based on the latest imaging and biomarker research.
- Identify promising areas of research for furthering our understanding of the factors influencing tau dissemination.
- Summarize the potential applications of the above knowledge in diagnosis, prognosis and novel treatment approaches for Alzheimer’s Disease, including noninvasive brain stimulation.
FACULTY DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
For this accredited continuing educational activity all relevant financial relationships have been mitigated and detailed disclosures are listed below:
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Elias Granadillo, MD | Presenter | No relevant financial relationships with ineligible companies to disclose | No |
| Terry Mangin, MD Department of Neurology University of Wisconsin School of Medicine and Public Health | RSS Chair | No relevant relationships with ineligible companies to disclose | No |
| Melissa Schroeder Department of Neurology University of Wisconsin School of Medicine and Public Health | RSS Coordinator | No relevant relationships with ineligible companies to disclose | No |
| Cole Butschke Department of Neurology University of Wisconsin School of Medicine and Public Health | RSS Coordinator | No relevant relationships with ineligible companies to disclose | No |
| Mihaela Bazalakova, MD, PhD Department of Neurology University of Wisconsin School of Medicine and Public Health | Planner | No relevant relationships with ineligible companies to disclose | No |
| Corinna Burger, PhD Department of Neurology University of Wisconsin School of Medicine and Public Health | Planner | No relevant relationships with ineligible companies to disclose | No |
| Joy White Department of Neurology University of Wisconsin School of Medicine and Public Health | Planner | No relevant relationships with ineligible companies to disclose | No |
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .1 continuing education units (CEUs) or 1.00 hour.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Registration for this activity can only be completed through the ICEP Learning Portal. Attendee registrations made through any other sites cannot be honored. UW-Madison ICEP is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to [email protected].
Accessibility
If you need anything to participate in this program, please contact [email protected]
Required Hardware/software
Computer, tablet, or other mobile device with sound.
Free, current version of Edge, Firefox, Safari, or Chrome. Some older browsers and Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.